The Market Reports
Call: +1-631-407-1315 / +91-750-729-1479
Email: sales@themarketreports.com
Global One-stop Pharmacy Research CDMO Market Research Report 2024
Synopsis
A one-stop pharmacy research CDMO refers to a contract development and manufacturing organization that provides a full range of pharmaceutical research services. It provides a package solution from drug discovery, drug development to pre-clinical trial research to accelerate the development process of new drugs.
Global One-stop Pharmacy Research CDMO market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole One-stop Pharmacy Research CDMO market research.
A one-stop pharmacy research CDMO usually covers the following services: drug discovery, pharmacological research, drug formulation development, synthesis and analytical method development, adverse event reporting and monitoring, pre-clinical trial research, GMP manufacturing. By providing a full range of pharmaceutical research services, the one-stop pharmacy research CDMO can help pharmaceutical companies shorten the R&D cycle, reduce R&D costs, improve product quality, and provide integrated solutions to provide comprehensive support for the R&D work of pharmaceutical companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global One-stop Pharmacy Research CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Langhua Pharmaceutical
Viva Biotech
Zhejiang Jiuzhou Pharmaceutical
Shanghai Porton Zhihui Biopharmaceutical
Boji Pharmaceutical Technology
GenScript ProBio
Asymchem Laboratories (Tianjin)
Beijing Sun-novo Pharmaceutical Research
Arthur Pharma
Segment by Type
API+Preparation
API+Intermediate+Preparation
Segment by Application
Innovative Drugs
Generic Drugs
Improved Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The One-stop Pharmacy Research CDMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
A one-stop pharmacy research CDMO refers to a contract development and manufacturing organization that provides a full range of pharmaceutical research services. It provides a package solution from drug discovery, drug development to pre-clinical trial research to accelerate the development process of new drugs.
Global One-stop Pharmacy Research CDMO market is projected to reach US$ million in 2029, increasing from US$ million in 2022, with the CAGR of % during the period of 2023 to 2029. Influencing issues, such as economy environments, COVID-19 and Russia-Ukraine War, have led to great market fluctuations in the past few years and are considered comprehensively in the whole One-stop Pharmacy Research CDMO market research.
A one-stop pharmacy research CDMO usually covers the following services: drug discovery, pharmacological research, drug formulation development, synthesis and analytical method development, adverse event reporting and monitoring, pre-clinical trial research, GMP manufacturing. By providing a full range of pharmaceutical research services, the one-stop pharmacy research CDMO can help pharmaceutical companies shorten the R&D cycle, reduce R&D costs, improve product quality, and provide integrated solutions to provide comprehensive support for the R&D work of pharmaceutical companies.
Report Scope
This report, based on historical analysis (2018-2022) and forecast calculation (2023-2029), aims to help readers to get a comprehensive understanding of global One-stop Pharmacy Research CDMO market with multiple angles, which provides sufficient supports to readers’ strategy and decision making.
By Company
Medicilon
Gliead
Boehringer Ingelheim
Vertex
Mirati Therapeutics
AMPAC
Pfizer
Polypeptide
Bachem
Merck
Asymchem
Zhejiang Langhua Pharmaceutical
Viva Biotech
Zhejiang Jiuzhou Pharmaceutical
Shanghai Porton Zhihui Biopharmaceutical
Boji Pharmaceutical Technology
GenScript ProBio
Asymchem Laboratories (Tianjin)
Beijing Sun-novo Pharmaceutical Research
Arthur Pharma
Segment by Type
API+Preparation
API+Intermediate+Preparation
Segment by Application
Innovative Drugs
Generic Drugs
Improved Drugs
Others
By Region
North America
United States
Canada
Europe
Germany
France
UK
Italy
Russia
Nordic Countries
Rest of Europe
Asia-Pacific
China
Japan
South Korea
Southeast Asia
India
Australia
Rest of Asia
Latin America
Mexico
Brazil
Rest of Latin America
Middle East & Africa
Turkey
Saudi Arabia
UAE
Rest of MEA
The One-stop Pharmacy Research CDMO report covers below items:
Chapter 1: Product Basic Information (Definition, Type and Application)
Chapter 2: Global market size, regional market size. Market Opportunities and Challenges
Chapter 3: Companies’ Competition Patterns
Chapter 4: Product Type Analysis
Chapter 5: Product Application Analysis
Chapter 6 to 10: Country Level Value Analysis
Chapter 11: Companies’ Outline
Chapter 12: Market Conclusions
Chapter 13: Research Methodology and Data Source
Index1 Report Overview
1.1 Study Scope
1.2 Market Analysis by Type
1.2.1 Global One-stop Pharmacy Research CDMO Market Size Growth Rate by Type: 2018 VS 2022 VS 2029
1.2.2 API+Preparation
1.2.3 API+Intermediate+Preparation
1.3 Market by Application
1.3.1 Global One-stop Pharmacy Research CDMO Market Growth by Application: 2018 VS 2022 VS 2029
1.3.2 Innovative Drugs
1.3.3 Generic Drugs
1.3.4 Improved Drugs
1.3.5 Others
1.4 Study Objectives
1.5 Years Considered
1.6 Years Considered
2 Global Growth Trends
2.1 Global One-stop Pharmacy Research CDMO Market Perspective (2018-2029)
2.2 One-stop Pharmacy Research CDMO Growth Trends by Region
2.2.1 Global One-stop Pharmacy Research CDMO Market Size by Region: 2018 VS 2022 VS 2029
2.2.2 One-stop Pharmacy Research CDMO Historic Market Size by Region (2018-2023)
2.2.3 One-stop Pharmacy Research CDMO Forecasted Market Size by Region (2024-2029)
2.3 One-stop Pharmacy Research CDMO Market Dynamics
2.3.1 One-stop Pharmacy Research CDMO Industry Trends
2.3.2 One-stop Pharmacy Research CDMO Market Drivers
2.3.3 One-stop Pharmacy Research CDMO Market Challenges
2.3.4 One-stop Pharmacy Research CDMO Market Restraints
3 Competition Landscape by Key Players
3.1 Global Top One-stop Pharmacy Research CDMO Players by Revenue
3.1.1 Global Top One-stop Pharmacy Research CDMO Players by Revenue (2018-2023)
3.1.2 Global One-stop Pharmacy Research CDMO Revenue Market Share by Players (2018-2023)
3.2 Global One-stop Pharmacy Research CDMO Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
3.3 Players Covered: Ranking by One-stop Pharmacy Research CDMO Revenue
3.4 Global One-stop Pharmacy Research CDMO Market Concentration Ratio
3.4.1 Global One-stop Pharmacy Research CDMO Market Concentration Ratio (CR5 and HHI)
3.4.2 Global Top 10 and Top 5 Companies by One-stop Pharmacy Research CDMO Revenue in 2022
3.5 One-stop Pharmacy Research CDMO Key Players Head office and Area Served
3.6 Key Players One-stop Pharmacy Research CDMO Product Solution and Service
3.7 Date of Enter into One-stop Pharmacy Research CDMO Market
3.8 Mergers & Acquisitions, Expansion Plans
4 One-stop Pharmacy Research CDMO Breakdown Data by Type
4.1 Global One-stop Pharmacy Research CDMO Historic Market Size by Type (2018-2023)
4.2 Global One-stop Pharmacy Research CDMO Forecasted Market Size by Type (2024-2029)
5 One-stop Pharmacy Research CDMO Breakdown Data by Application
5.1 Global One-stop Pharmacy Research CDMO Historic Market Size by Application (2018-2023)
5.2 Global One-stop Pharmacy Research CDMO Forecasted Market Size by Application (2024-2029)
6 North America
6.1 North America One-stop Pharmacy Research CDMO Market Size (2018-2029)
6.2 North America One-stop Pharmacy Research CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
6.3 North America One-stop Pharmacy Research CDMO Market Size by Country (2018-2023)
6.4 North America One-stop Pharmacy Research CDMO Market Size by Country (2024-2029)
6.5 United States
6.6 Canada
7 Europe
7.1 Europe One-stop Pharmacy Research CDMO Market Size (2018-2029)
7.2 Europe One-stop Pharmacy Research CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
7.3 Europe One-stop Pharmacy Research CDMO Market Size by Country (2018-2023)
7.4 Europe One-stop Pharmacy Research CDMO Market Size by Country (2024-2029)
7.5 Germany
7.6 France
7.7 U.K.
7.8 Italy
7.9 Russia
7.10 Nordic Countries
8 Asia-Pacific
8.1 Asia-Pacific One-stop Pharmacy Research CDMO Market Size (2018-2029)
8.2 Asia-Pacific One-stop Pharmacy Research CDMO Market Growth Rate by Region: 2018 VS 2022 VS 2029
8.3 Asia-Pacific One-stop Pharmacy Research CDMO Market Size by Region (2018-2023)
8.4 Asia-Pacific One-stop Pharmacy Research CDMO Market Size by Region (2024-2029)
8.5 China
8.6 Japan
8.7 South Korea
8.8 Southeast Asia
8.9 India
8.10 Australia
9 Latin America
9.1 Latin America One-stop Pharmacy Research CDMO Market Size (2018-2029)
9.2 Latin America One-stop Pharmacy Research CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
9.3 Latin America One-stop Pharmacy Research CDMO Market Size by Country (2018-2023)
9.4 Latin America One-stop Pharmacy Research CDMO Market Size by Country (2024-2029)
9.5 Mexico
9.6 Brazil
10 Middle East & Africa
10.1 Middle East & Africa One-stop Pharmacy Research CDMO Market Size (2018-2029)
10.2 Middle East & Africa One-stop Pharmacy Research CDMO Market Growth Rate by Country: 2018 VS 2022 VS 2029
10.3 Middle East & Africa One-stop Pharmacy Research CDMO Market Size by Country (2018-2023)
10.4 Middle East & Africa One-stop Pharmacy Research CDMO Market Size by Country (2024-2029)
10.5 Turkey
10.6 Saudi Arabia
10.7 UAE
11 Key Players Profiles
11.1 Medicilon
11.1.1 Medicilon Company Detail
11.1.2 Medicilon Business Overview
11.1.3 Medicilon One-stop Pharmacy Research CDMO Introduction
11.1.4 Medicilon Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.1.5 Medicilon Recent Development
11.2 Gliead
11.2.1 Gliead Company Detail
11.2.2 Gliead Business Overview
11.2.3 Gliead One-stop Pharmacy Research CDMO Introduction
11.2.4 Gliead Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.2.5 Gliead Recent Development
11.3 Boehringer Ingelheim
11.3.1 Boehringer Ingelheim Company Detail
11.3.2 Boehringer Ingelheim Business Overview
11.3.3 Boehringer Ingelheim One-stop Pharmacy Research CDMO Introduction
11.3.4 Boehringer Ingelheim Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.3.5 Boehringer Ingelheim Recent Development
11.4 Vertex
11.4.1 Vertex Company Detail
11.4.2 Vertex Business Overview
11.4.3 Vertex One-stop Pharmacy Research CDMO Introduction
11.4.4 Vertex Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.4.5 Vertex Recent Development
11.5 Mirati Therapeutics
11.5.1 Mirati Therapeutics Company Detail
11.5.2 Mirati Therapeutics Business Overview
11.5.3 Mirati Therapeutics One-stop Pharmacy Research CDMO Introduction
11.5.4 Mirati Therapeutics Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.5.5 Mirati Therapeutics Recent Development
11.6 AMPAC
11.6.1 AMPAC Company Detail
11.6.2 AMPAC Business Overview
11.6.3 AMPAC One-stop Pharmacy Research CDMO Introduction
11.6.4 AMPAC Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.6.5 AMPAC Recent Development
11.7 Pfizer
11.7.1 Pfizer Company Detail
11.7.2 Pfizer Business Overview
11.7.3 Pfizer One-stop Pharmacy Research CDMO Introduction
11.7.4 Pfizer Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.7.5 Pfizer Recent Development
11.8 Polypeptide
11.8.1 Polypeptide Company Detail
11.8.2 Polypeptide Business Overview
11.8.3 Polypeptide One-stop Pharmacy Research CDMO Introduction
11.8.4 Polypeptide Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.8.5 Polypeptide Recent Development
11.9 Bachem
11.9.1 Bachem Company Detail
11.9.2 Bachem Business Overview
11.9.3 Bachem One-stop Pharmacy Research CDMO Introduction
11.9.4 Bachem Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.9.5 Bachem Recent Development
11.10 Merck
11.10.1 Merck Company Detail
11.10.2 Merck Business Overview
11.10.3 Merck One-stop Pharmacy Research CDMO Introduction
11.10.4 Merck Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.10.5 Merck Recent Development
11.11 Asymchem
11.11.1 Asymchem Company Detail
11.11.2 Asymchem Business Overview
11.11.3 Asymchem One-stop Pharmacy Research CDMO Introduction
11.11.4 Asymchem Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.11.5 Asymchem Recent Development
11.12 Zhejiang Langhua Pharmaceutical
11.12.1 Zhejiang Langhua Pharmaceutical Company Detail
11.12.2 Zhejiang Langhua Pharmaceutical Business Overview
11.12.3 Zhejiang Langhua Pharmaceutical One-stop Pharmacy Research CDMO Introduction
11.12.4 Zhejiang Langhua Pharmaceutical Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.12.5 Zhejiang Langhua Pharmaceutical Recent Development
11.13 Viva Biotech
11.13.1 Viva Biotech Company Detail
11.13.2 Viva Biotech Business Overview
11.13.3 Viva Biotech One-stop Pharmacy Research CDMO Introduction
11.13.4 Viva Biotech Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.13.5 Viva Biotech Recent Development
11.14 Zhejiang Jiuzhou Pharmaceutical
11.14.1 Zhejiang Jiuzhou Pharmaceutical Company Detail
11.14.2 Zhejiang Jiuzhou Pharmaceutical Business Overview
11.14.3 Zhejiang Jiuzhou Pharmaceutical One-stop Pharmacy Research CDMO Introduction
11.14.4 Zhejiang Jiuzhou Pharmaceutical Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.14.5 Zhejiang Jiuzhou Pharmaceutical Recent Development
11.15 Shanghai Porton Zhihui Biopharmaceutical
11.15.1 Shanghai Porton Zhihui Biopharmaceutical Company Detail
11.15.2 Shanghai Porton Zhihui Biopharmaceutical Business Overview
11.15.3 Shanghai Porton Zhihui Biopharmaceutical One-stop Pharmacy Research CDMO Introduction
11.15.4 Shanghai Porton Zhihui Biopharmaceutical Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.15.5 Shanghai Porton Zhihui Biopharmaceutical Recent Development
11.16 Boji Pharmaceutical Technology
11.16.1 Boji Pharmaceutical Technology Company Detail
11.16.2 Boji Pharmaceutical Technology Business Overview
11.16.3 Boji Pharmaceutical Technology One-stop Pharmacy Research CDMO Introduction
11.16.4 Boji Pharmaceutical Technology Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.16.5 Boji Pharmaceutical Technology Recent Development
11.17 GenScript ProBio
11.17.1 GenScript ProBio Company Detail
11.17.2 GenScript ProBio Business Overview
11.17.3 GenScript ProBio One-stop Pharmacy Research CDMO Introduction
11.17.4 GenScript ProBio Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.17.5 GenScript ProBio Recent Development
11.18 Asymchem Laboratories (Tianjin)
11.18.1 Asymchem Laboratories (Tianjin) Company Detail
11.18.2 Asymchem Laboratories (Tianjin) Business Overview
11.18.3 Asymchem Laboratories (Tianjin) One-stop Pharmacy Research CDMO Introduction
11.18.4 Asymchem Laboratories (Tianjin) Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.18.5 Asymchem Laboratories (Tianjin) Recent Development
11.19 Beijing Sun-novo Pharmaceutical Research
11.19.1 Beijing Sun-novo Pharmaceutical Research Company Detail
11.19.2 Beijing Sun-novo Pharmaceutical Research Business Overview
11.19.3 Beijing Sun-novo Pharmaceutical Research One-stop Pharmacy Research CDMO Introduction
11.19.4 Beijing Sun-novo Pharmaceutical Research Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.19.5 Beijing Sun-novo Pharmaceutical Research Recent Development
11.20 Arthur Pharma
11.20.1 Arthur Pharma Company Detail
11.20.2 Arthur Pharma Business Overview
11.20.3 Arthur Pharma One-stop Pharmacy Research CDMO Introduction
11.20.4 Arthur Pharma Revenue in One-stop Pharmacy Research CDMO Business (2018-2023)
11.20.5 Arthur Pharma Recent Development
12 Analyst's Viewpoints/Conclusions
13 Appendix
13.1 Research Methodology
13.1.1 Methodology/Research Approach
13.1.2 Data Source
13.2 Disclaimer
13.3 Author Details
Published By : QY Research
Why ‘The Market Reports’
In Business:
Pre Sales Support:
Post Sales Support:
Turn Around Time:
Clients Served:
Clients Assisted:
Client Types:
Payment:
- Accept global payments [Credit Card / PayPal / Wire Transfer]
- Accept local payments in South Korea, Germany, China and India [Can pay in local currency]
Latest Life Science Market Reports
Payments Accepted From
Connect with us at
Complete Secure Website
